Profil:
Sopharma ADSOPHARMA AD (35/2019) Consolidated financial report of Sopharma Group for Q2 2019
Report no 35/2019
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Financial report according to IFRS as at 30 June 2019 - consolidated
Notes to the financial report as at 30 June 2019 - consolidated
Management report as at 30 June 2019 - consolidated
Insider information as at 30 June 2019 - consolidated
Additional information as at 30 June 2019 - consolidated
Financial report according to BFCS standards as at 30 June 2019 - consolidated
Annex 9 as at 30 June 2019 - consolidated
Declaration as at 30 June 2019 - consolidated
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz